Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Vera S. Schellerer"'
Autor:
Elisabeth Naschberger, Christian Flierl, Jinghao Huang, Lena Erkert, Reyes Gamez-Belmonte, Miguel Gonzalez-Acera, Magdalena Bober, Martin Mehnert, Christoph Becker, Vera S. Schellerer, Nathalie Britzen-Laurent, Michael Stürzl
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
The development of inflammatory bowel diseases (IBD) involves the breakdown of two barriers: the epithelial barrier and the gut-vascular barrier (GVB). The destabilization of each barrier can promote initiation and progression of the disease. Interes
Externí odkaz:
https://doaj.org/article/53be4f93af2a406dad46c20f57c03bdf
Autor:
Elisabeth Naschberger, Maximilian Fuchs, Nicholas Dickel, Meik Kunz, Charles G. Anchang, Richard Demmler, Bernt Popp, Arif B. Ekici, Steffen Uebe, Carol I. Geppert, Claudia Günther, Susanne Merkel, Vera S. Schellerer, Michael Stürzl
Publikováno v:
Cancer Research. 83:4587-4587
Background: Antiangiogenic therapy is part of the guideline therapy of colorectal cancer (CRC). Surprisingly, the impact of the tumor microenvironment (TME) on tumor vessel endothelial cells (TECs) is largely unclear. The aim of this study was to inv
Autor:
Julian Fuchs, Vera S Schellerer, Maximilian Brunner, Carol I Geppert, Robert Grützmann, Klaus Weber, Susanne Merkel
Publikováno v:
International journal of colorectal disease. 37(5)
Background The impact of body mass index (BMI) on prognosis in patients with curatively resected stage I–III colon carcinoma was analyzed. Methods The prospectively collected data of 694 patients who underwent complete mesocolic excision between 20
Autor:
Julia Krug, Gabriele Rodrian, Katja Petter, Hai Yang, Svetlana Khoziainova, Wei Guo, Alan Bénard, Susanne Merkel, Susan Gellert, Simone Maschauer, Monika Spermann, Maximilian Waldner, Peter Bailey, Christian Pilarsky, Andrea Liebl, Philipp Tripal, Jan Christoph, Elisabeth Naschberger, Roland Croner, Vera S. Schellerer, Christoph Becker, Arndt Hartmann, Thomas Tüting, Olaf Prante, Robert Grützmann, Sergei I. Grivennikov, Michael Stürzl, Nathalie Britzen-Laurent
Publikováno v:
Gastroenterology.
Advanced colorectal carcinoma (CRC) is characterized by a high frequency of primary immune evasion and refractoriness to immunotherapy. Given the importance of interferon (IFN)-γ in CRC immunosurveillance, we investigated whether and how acquired IF
Autor:
Michael Stürzl, Maximilian Fuchs, Meik Kunz, Nicholas Dickel, Bernt Popp, Steffen Uebe, Arif B. Ekici, Carol I. Geppert, Susanne Merkel, Vera S. Schellerer, Elisabeth Naschberger
Publikováno v:
Cancer Research. 82:3802-3802
Purpose of the study: Tumor microenvironment (TME)-induced plasticity of fibroblasts and immune cells are known to contribute to cancer pathogenesis. In contrast, only little is known about the existence, stability, functions and prognostic potential
Autor:
Vera S, Schellerer, Larissa, Mueller-Bergh, Susanne, Merkel, Robert, Zimmermann, Dominik, Weiss, Anne, Schlabrakowski, Elisabeth, Naschberger, Michael, Stürzl, Werner, Hohenberger, Roland S, Croner
Publikováno v:
American journal of translational research. 3(5)
Background: To identify the value of von Willebrand factor (vWF) as a clinical marker in colorectal carcinoma (CRC). Methods: Plasma levels of vWF were measured in 79 patients with UICC Stage I-IV CRC at time of operation and correlated with TNM cate
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 731
Antiangiogenic drugs have been used successfully for the treatment of colorectal cancer (CRC) and several other tumor types. Until recently, viable tumor endothelial cells (TEC) and normal endothelial cells of uninvolved colon tissue (NEC) from the s